Enabling Flexibility For T Cell Isolation And Activation Using Workflows

As cell therapies continue to advance, the industry benefits from manufacturing platforms that evolve alongside developments in workflow design, scale, and regulatory demand. While fully closed, time-locked systems can be effective for standardized processes, they may constrain adaptability during early development. Manufacturing teams must balance process control and robustness with the need for flexibility.  Download now to see this brief overview and learn even more to see the full report by scanning the QR code.